Zachary Schafer

Dr. Zachary Schafer

Department of Biological Sciences, University of Notre Dame, 222 Galvin Life Science Center, Notre Dame, IN 46556, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
JSJames H. Schofield
James H. Schofield
ZSZachary Schafer
Zachary Schafer
Significance: Mitochondria represent a major source of intracellular reactive oxygen species (ROS) generation. This is often a consequence of oxidative phosphorylation, which can produce ROS as a result of leakage from the electron transport chain. In addition, quality control mechanisms exist to protect cells from cytotoxic ROS production. One such mechanism is selective autophagic degradation of ROS-producing mitochondria, termed mitophagy, that ultimately results in elimination of mitochondria in the lysosome. Recent Advances: However, while the relationship between mitophagy and ROS production is clearly interwoven, it is yet to be fully untangled. In some circumstances, mitochondrial ROS (mtROS) are elevated as a consequence of mitophagy induction. Critical Issues: In this review, we discuss mtROS generation and their detrimental effects on cellular viability. In addition, we consider the cellular defense mechanisms that the eukaryotic cell uses to abrogate superfluous oxidative stress. In particular, we delve into the prominent mechanisms governing mitophagy induction that bear on oxidative stress. Future Directions: Finally, we examine the pathological conditions associated with defective mitophagy, where additional research may help to facilitate understanding.

26 February 2016 in Cell Death & Differentiation
Verified
Journal Article
Closed access
JMJ A Mason
J A Mason
CDC A Davison-Versagli
C A Davison-Versagli
ALA K Leliaert
A K Leliaert
DPD J Pape
D J Pape
CMC McCallister
C McCallister
ZSZachary Schafer
Zachary Schafer

19 February 2018 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
MHMark A. Hawk
Mark A. Hawk
CGCassandra L. Gorsuch
Cassandra L. Gorsuch
PFPatrick Fagan
Patrick Fagan
CLChan Lee
Chan Lee
SKSung Eun Kim
Sung Eun Kim
ZSZachary Schafer
Zachary Schafer

8 April 2024 in Cancer Research
Verified
Journal Article
Open access
PDF file
SMSean Murphy
Sean Murphy
SRSharif Rahmy
Sharif Rahmy
DGDailin Gan
Dailin Gan
GLGuoqiang Liu
Guoqiang Liu
YZYini Zhu
Yini Zhu
Xin LuXin Lu
Xin Lu
Resistance to immune checkpoint blockade (ICB) therapy represents a formidable clinical challenge limiting the efficacy of immunotherapy. In particular, prostate cancer poses a challenge for ICB therapy due to its immunosuppressive features. A ketogenic diet (KD) has been reported to enhance response to ICB therapy in some other cancer models. However, adverse effects associated with continuous KD were also observed, demanding better mechanistic understanding and optimized regimens for using KD as an immunotherapy sensitizer. In this study, we established a series of ICB-resistant prostate cancer cell lines and developed a highly effective strategy of combining anti-PD1 and anti-CTLA4 antibodies with histone deacetylase inhibitor (HDACi) vorinostat, a cyclic KD (CKD), or dietary supplementation of the ketone body β-hydroxybutyrate (BHB), which is an endogenous HDACi. CKD and BHB supplementation each delayed prostate cancer tumor growth as monotherapy, and both BHB and adaptive immunity were required for the antitumor activity of CKD. Single-cell transcriptomic and proteomic profiling revealed that HDACi and ketogenesis enhanced ICB efficacy through both cancer cell–intrinsic mechanisms, including upregulation of MHC class I molecules, and -extrinsic mechanisms, such as CD8+ T-cell chemoattraction, M1/M2 macrophage rebalancing, monocyte differentiation toward antigen-presenting cells, and diminished neutrophil infiltration. Overall, these findings illuminate a potential clinical path of using HDACi and optimized KD regimens to enhance ICB therapy for prostate cancer. Significance: Optimized cyclic ketogenic diet and 1,3-butanediol supplementation regimens enhance the efficacy of immune checkpoint blockade in prostate cancer through epigenetic and immune modulations, providing dietary interventions to sensitize tumors to immunotherapy.

1 July 2017 in Trends in Cancer
Verified
Journal Article
Closed access
JMJoshua A. Mason
Joshua A. Mason
KHKimberly R. Hagel
Kimberly R. Hagel
MHMark A. Hawk
Mark A. Hawk
ZSZachary Schafer
Zachary Schafer

1 May 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MHMark A. Hawk
Mark A. Hawk
ZSZachary Schafer
Zachary Schafer
Non-transformed cells that become detached from the extracellular matrix (ECM) undergo dysregulation of redox homeostasis and cell death. In contrast, cancer cells often acquire the ability to mitigate programmed cell death pathways and recalibrate the redox balance to survive after ECM detachment, facilitating metastatic dissemination. Accordingly, recent studies of the mechanisms by which cancer cells overcome ECM detachment–induced metabolic alterations have focused on mechanisms in redox homeostasis. The insights into these mechanisms may inform the development of therapeutics that manipulate redox homeostasis to eliminate ECM-detached cancer cells. Here, we review how ECM-detached cancer cells balance redox metabolism for survival.